Novo Nordisk Drug Helps With Weight, Blood Sugar

Novo Nordisk said a weight-loss drug candidate helped patients lose weight and reduce blood-sugar levels in pill and injection forms during a mid-stage trial, lifting shares in the company.

- By ApriA CALATAYUD

The Danish drugmaker is working to line up potential successors to its Wegovy and Ozempic blockbuster drugs for obesity and diabetes as it seeks to turn a page on a challenging year that saw the company reshuffle its leadership and board, cut jobs